• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症性肝脏与动脉粥样硬化:非酒精性脂肪性肝病组织学严重程度与心血管风险增加之间的联系。

The inflamed liver and atherosclerosis: a link between histologic severity of nonalcoholic fatty liver disease and increased cardiovascular risk.

机构信息

Department of Pediatric Gastroenterology, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA.

出版信息

Dig Dis Sci. 2010 Sep;55(9):2644-50. doi: 10.1007/s10620-009-1075-y. Epub 2009 Dec 5.

DOI:10.1007/s10620-009-1075-y
PMID:19960252
Abstract

BACKGROUND

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the Western world. It encompasses a spectrum of disease ranging from simple steatosis to nonalcoholic steatohepatitis (NASH). Growing evidence links NAFLD to cardiovascular (CV) disease; however, the association between the histologic severity of NAFLD and CV risk remains poorly understood.

AIM

To assess the relationship between severity of liver injury and CV risk markers in a large, well-characterized group of patients with biopsy-proven NAFLD.

METHODS

Our cohort consisted of 83 consecutive patients undergoing liver biopsy for clinical suspicion of NAFLD. Patients were subsequently divided into three groups: normal biopsy (n=11) simple steatosis (n=36), and NASH (n=36). CV risk markers included: triglyceride/high-density lipoprotein (HDL), total cholesterol/HDL, and low-density lipoprotein/HDL ratios.

RESULTS

All lipid ratios were found to be significantly associated with NAFLD (p<0.05) after adjusting for age and gender. More importantly, there was a stepwise, statistically significant increase in lipid ratios from patients with normal biopsies to patients with simple steatosis to those with NASH (p<0.05). A positive correlation was found between the lipid ratios and NAFLD activity score (NAS) as well as the individual histological features of the NAS (steatosis, inflammation, and ballooning) with the strongest correlation being with NAS (rho (95% CI) 0.41 (0.21, 0.62), p<0.001).

CONCLUSION

In patients with NAFLD, the histologic severity of liver injury and inflammation is strongly associated with an increased CV risk and an atherogenic lipid profile.

摘要

背景

非酒精性脂肪性肝病(NAFLD)是西方世界最常见的慢性肝病。它包含了从单纯性脂肪变性到非酒精性脂肪性肝炎(NASH)的一系列疾病谱。越来越多的证据将 NAFLD 与心血管(CV)疾病联系起来;然而,NAFLD 的组织学严重程度与 CV 风险之间的关系仍知之甚少。

目的

在一组经活检证实的 NAFLD 大样本、特征明确的患者中,评估肝损伤严重程度与 CV 风险标志物之间的关系。

方法

我们的队列包括 83 例因临床怀疑 NAFLD 而行肝活检的连续患者。随后,患者被分为三组:正常活检组(n=11)、单纯性脂肪变性组(n=36)和 NASH 组(n=36)。CV 风险标志物包括甘油三酯/高密度脂蛋白(HDL)、总胆固醇/HDL 和低密度脂蛋白/HDL 比值。

结果

调整年龄和性别后,所有血脂比值均与 NAFLD 显著相关(p<0.05)。更重要的是,从正常活检患者到单纯性脂肪变性患者再到 NASH 患者,血脂比值呈逐步、统计学显著增加(p<0.05)。血脂比值与 NAFLD 活动评分(NAS)以及 NAS 的各个组织学特征(脂肪变性、炎症和气球样变)呈正相关,与 NAS 的相关性最强(rho(95%CI)0.41(0.21,0.62),p<0.001)。

结论

在 NAFLD 患者中,肝损伤和炎症的组织学严重程度与 CV 风险增加和动脉粥样硬化性血脂谱密切相关。

相似文献

1
The inflamed liver and atherosclerosis: a link between histologic severity of nonalcoholic fatty liver disease and increased cardiovascular risk.炎症性肝脏与动脉粥样硬化:非酒精性脂肪性肝病组织学严重程度与心血管风险增加之间的联系。
Dig Dis Sci. 2010 Sep;55(9):2644-50. doi: 10.1007/s10620-009-1075-y. Epub 2009 Dec 5.
2
Oxidized low-density lipoprotein antibodies/high-density lipoprotein cholesterol ratio is linked to advanced non-alcoholic fatty liver disease lean patients.氧化型低密度脂蛋白抗体/高密度脂蛋白胆固醇比值与晚期非酒精性脂肪性肝病瘦患者有关。
J Gastroenterol Hepatol. 2016 Sep;31(9):1611-8. doi: 10.1111/jgh.13335.
3
Severity of liver injury and atherogenic lipid profile in children with nonalcoholic fatty liver disease.非酒精性脂肪性肝病患儿的肝损伤严重程度和动脉粥样硬化脂质谱。
Pediatr Res. 2010 Jun;67(6):665-70. doi: 10.1203/PDR.0b013e3181da4798.
4
Low- and high-density lipoprotein subclasses in subjects with nonalcoholic fatty liver disease.非酒精性脂肪性肝病患者的低密度和高密度脂蛋白亚类
J Clin Lipidol. 2015 Jul-Aug;9(4):576-82. doi: 10.1016/j.jacl.2015.03.010. Epub 2015 Apr 4.
5
OxNASH score correlates with histologic features and severity of nonalcoholic fatty liver disease.OxNASH 评分与非酒精性脂肪性肝病的组织学特征和严重程度相关。
Dig Dis Sci. 2014 Jul;59(7):1617-24. doi: 10.1007/s10620-014-3031-8. Epub 2014 Jan 25.
6
Triglyceride levels and not adipokine concentrations are closely related to severity of nonalcoholic fatty liver disease in an obesity surgery cohort.在一个肥胖症手术队列中,甘油三酯水平而非脂肪因子浓度与非酒精性脂肪性肝病的严重程度密切相关。
Obesity (Silver Spring). 2009 Sep;17(9):1696-701. doi: 10.1038/oby.2009.89. Epub 2009 Apr 9.
7
Novel Application of the Traditional Lipid Ratios as Strong Risk Predictors of NASH.传统脂质比率作为非酒精性脂肪性肝炎强风险预测指标的新应用。
Diabetes Metab Syndr Obes. 2020 Feb 10;13:297-305. doi: 10.2147/DMSO.S229590. eCollection 2020.
8
Hepatic Steatosis and Insulin Resistance, But Not Steatohepatitis, Promote Atherogenic Dyslipidemia in NAFLD.肝脂肪变性和胰岛素抵抗而非脂肪性肝炎促进非酒精性脂肪性肝病中的致动脉粥样硬化血脂异常。
J Clin Endocrinol Metab. 2016 Feb;101(2):644-52. doi: 10.1210/jc.2015-3111. Epub 2015 Dec 16.
9
Irisin in patients with nonalcoholic fatty liver disease.非酒精性脂肪性肝病患者的鸢尾素。
Metabolism. 2014 Feb;63(2):207-17. doi: 10.1016/j.metabol.2013.09.013. Epub 2013 Oct 18.
10
Polymorphism in microsomal triglyceride transfer protein: a link between liver disease and atherogenic postprandial lipid profile in NASH?微粒体甘油三酯转运蛋白的多态性:非酒精性脂肪性肝炎中肝脏疾病与餐后致动脉粥样硬化脂质谱之间的联系?
Hepatology. 2007 May;45(5):1097-107. doi: 10.1002/hep.21631.

引用本文的文献

1
Association between liver fibrosis scores and cardiovascular disease in elderly based on NHANES 1999-2018.基于1999 - 2018年美国国家健康与营养检查调查(NHANES)的老年人肝纤维化评分与心血管疾病之间的关联
Sci Rep. 2025 Jul 2;15(1):23334. doi: 10.1038/s41598-025-06871-4.
2
European System for Cardiac Operative Risk Evaluation II and Liver Dysfunction.欧洲心脏手术风险评估系统II与肝功能障碍
Biomedicines. 2025 Jan 10;13(1):154. doi: 10.3390/biomedicines13010154.
3
Association between fatty liver index and cardiometabolic multimorbidity: evidence from the cross-sectional national health and nutrition examination survey.

本文引用的文献

1
Diagnosis of nonalcoholic fatty liver disease: invasive versus noninvasive.非酒精性脂肪性肝病的诊断:有创与无创诊断方法
Semin Liver Dis. 2008 Nov;28(4):386-95. doi: 10.1055/s-0028-1091983. Epub 2008 Oct 27.
2
Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis.人类非酒精性脂肪性肝炎中肝脏和循环中白细胞介素-6水平升高。
Am J Gastroenterol. 2008 Jun;103(6):1372-9. doi: 10.1111/j.1572-0241.2007.01774.x. Epub 2008 May 28.
3
The triglyceride/HDL-cholesterol ratio as a marker of cardiovascular risk in obese children; association with traditional and emergent risk factors.
脂肪肝指数与心血管代谢多种疾病之间的关联:来自横断面全国健康与营养检查调查的证据
Front Cardiovasc Med. 2024 Sep 5;11:1433807. doi: 10.3389/fcvm.2024.1433807. eCollection 2024.
4
The Burden of Nonalcoholic Steatohepatitis: A Systematic Review of Epidemiology Studies.非酒精性脂肪性肝炎的负担:流行病学研究的系统评价
Gastro Hep Adv. 2022 Jul 19;1(6):1049-1087. doi: 10.1016/j.gastha.2022.06.016. eCollection 2022.
5
Alanine aminotransferase as a risk marker for new-onset metabolic dysfunction-associated fatty liver disease.丙氨酸氨基转移酶作为代谢相关脂肪性肝病新发病变的风险标志物。
World J Gastroenterol. 2024 Jul 7;30(25):3132-3139. doi: 10.3748/wjg.v30.i25.3132.
6
Significance of fatty liver index to detect prevalent ischemic heart disease: evidence from national health and nutrition examination survey 1999-2016.脂肪肝指数对检测缺血性心脏病患病率的意义:来自1999 - 2016年美国国家健康与营养检查调查的证据
Front Cardiovasc Med. 2023 Oct 12;10:1171754. doi: 10.3389/fcvm.2023.1171754. eCollection 2023.
7
Liver stiffness measurement identifies subclinical myocardial dysfunction in non-advanced non-alcoholic fatty liver disease patients without overt heart disease.肝脏硬度测量可在无明显心脏疾病的非进展期非酒精性脂肪性肝病患者中识别亚临床心肌功能障碍。
Intern Emerg Med. 2022 Aug;17(5):1425-1438. doi: 10.1007/s11739-022-02966-2. Epub 2022 Mar 17.
8
Jiang Zhi Granule protects immunological barrier of intestinal mucosa in rats with non-alcoholic steatohepatitis.姜至颗粒对非酒精性脂肪性肝炎大鼠肠黏膜免疫屏障的保护作用。
Pharm Biol. 2021 Dec;59(1):1359-1368. doi: 10.1080/13880209.2021.1979594.
9
AST to Platelet Ratio Index (APRI) is an easy-to-use predictor score for cardiovascular risk in metabolic subjects.天门冬氨酸氨基转移酶与血小板比值指数(APRI)是代谢性疾病患者心血管风险的一种易于使用的预测评分指标。
Sci Rep. 2021 Jul 21;11(1):14834. doi: 10.1038/s41598-021-94277-3.
10
Interplay between Heart Disease and Metabolic Steatosis: A Contemporary Perspective.心脏病与代谢性脂肪变性之间的相互作用:当代视角
J Clin Med. 2021 Apr 8;10(8):1569. doi: 10.3390/jcm10081569.
甘油三酯/高密度脂蛋白胆固醇比值作为肥胖儿童心血管风险的标志物;与传统和新出现的风险因素的关联。
Pediatr Diabetes. 2008 Oct;9(5):464-71. doi: 10.1111/j.1399-5448.2008.00406.x. Epub 2008 May 23.
4
Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis.肝脏胰岛素抵抗足以导致血脂异常和动脉粥样硬化易感性。
Cell Metab. 2008 Feb;7(2):125-34. doi: 10.1016/j.cmet.2007.11.013.
5
Squalene in a sex-dependent manner modulates atherosclerotic lesion which correlates with hepatic fat content in apoE-knockout male mice.角鲨烯以性别依赖性方式调节动脉粥样硬化病变,这与载脂蛋白E基因敲除雄性小鼠的肝脏脂肪含量相关。
Atherosclerosis. 2008 Mar;197(1):72-83. doi: 10.1016/j.atherosclerosis.2007.08.008. Epub 2007 Sep 12.
6
Intrahepatic fat accumulation and alterations in lipoprotein composition in obese adolescents: a perfect proatherogenic state.肥胖青少年的肝内脂肪堆积及脂蛋白组成改变:一种典型的促动脉粥样硬化状态。
Diabetes Care. 2007 Dec;30(12):3093-8. doi: 10.2337/dc07-1088. Epub 2007 Aug 23.
7
Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular events in type 2 diabetic patients.非酒精性脂肪性肝病与2型糖尿病患者心血管事件发生率增加独立相关。
Diabetes Care. 2007 Aug;30(8):2119-21. doi: 10.2337/dc07-0349. Epub 2007 May 22.
8
Obesity, inflammation, and insulin resistance.肥胖、炎症与胰岛素抵抗。
Gastroenterology. 2007 May;132(6):2169-80. doi: 10.1053/j.gastro.2007.03.059.
9
Plasma PAI-1 levels are increased in patients with nonalcoholic steatohepatitis.非酒精性脂肪性肝炎患者的血浆纤溶酶原激活物抑制剂-1(PAI-1)水平升高。
Diabetes Care. 2007 May;30(5):e31-2. doi: 10.2337/dc07-0109.
10
Non-alcoholic fatty liver disease, the metabolic syndrome and the risk of cardiovascular disease: the plot thickens.非酒精性脂肪性肝病、代谢综合征与心血管疾病风险:情况愈发复杂。
Diabet Med. 2007 Jan;24(1):1-6. doi: 10.1111/j.1464-5491.2007.02025.x.